US Stock MarketDetailed Quotes

CTXR Citius Pharmaceuticals

Watchlist
  • 3.3000
  • +0.0400+1.23%
Close Jan 17 16:00 ET
  • 3.1800
  • -0.1200-3.64%
Post 19:55 ET
28.36MMarket Cap-0.55P/E (TTM)

Citius Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Citius Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 2.668M--
--2025/Q1-- / 0.000--
--2024/Q40.000 / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 2.668M--
--2025/Q1-- / 0.000--
--2024/Q40.000 / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--

Unlock Free Earnings Estimates

Citius Pharmaceuticals Earnings Reports

  • 10-K: FY2024 Annual Report

    Dec 27, 2024 17:03 ET

  • 8-K: Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2024 Financial Results and Provides Business Update

    Aug 12, 2024 17:27 ET

  • 10-Q: Q3 2024 Earnings Report

    Aug 12, 2024 16:56 ET

  • 10-Q: Q2 2024 Earnings Report

    May 14, 2024 16:43 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Hutchmed (China)
    HCM
    +6.61%
    Ermenegildo Zegna NV
    ZGN
    +2.34%
    New Fortress Energy
    NFE
    +2.32%
    Enerpac Tool
    EPAC
    +1.91%
    eBay
    EBAY
    +1.74%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Jan 19, 2025

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data